For example, tumor-infiltrating lymphocytes were dramatically reduced in EGFR-mutated lung cancer [12]; whereas CD8 + T cells were either absent or functionally impaired in ALK-positive lung cancer [11, 46]. This evidence concerns the gene CD8A and lung carcinoma.